Fructose-1,6-Diphosphate

HCID 445557CAS 34693-23-7

基本情報

標準SMILES: O=P(O)(O)OC[C@H]1O[C@@](O)(COP(=O)(O)O)[C@@H](O)[C@@H]1O
InChIKey: RNBGYGVWRKECFJ-ZXXMMSQZSA-N
分子式: C6H14O12P2
平均分子量: 340.12 g/mol

概要

Alpha-D-fructofuranose 1,6-bisphosphate is a D-fructofuranose 1,6-bisphosphate with an alpha-configuration at the anomeric position. It is functionally related to an alpha-D-fructofuranose. It is a conjugate acid of an alpha-D-fructofuranose 1,6-bisphosphate(4-).

名称と識別子

優先名称: Fructose-1,6-Diphosphate
IUPAC: [(2S,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate

名称と別名

fructose-1,6-diphosphateFructose 1,6-diphosphate[(2S,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate((2S,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl)methyl dihydrogen phosphateSr-FDPRefChem:600595GlyTouCan:G18745STstrontium fructose-1,6-diphosphateG18745STANW5CM3PJ7alpha-D-FosfructofuranoseUNII-ANW5CM3PJ7

名称をさらに表示

NSC-575531,6-di-O-phosphono-alpha-D-fructofuranoseCHEMBL1089962alpha-D-Fructofuranose 1,6-diphosphatealpha-D-fructofuranose 1,6-bisphosphatealpha-D-Fructofuranose, 1,6-bis(dihydrogen phosphate)fructose-1,6-bisphosphateAFP

データベース識別子

CAS: 34693-23-7
PubChem CID: 445557
ChEMBL: CHEMBL1089962
ChEBI: CHEBI:40595
UNII: ANW5CM3PJ7
Nikkaji: J792.775D

物性

構造計算による物性

XLogP: -5.6
極性表面積: 203 Å²
水素結合供与体数: 7
水素結合受容体数: 12
回転可能結合数: 6
重原子数: 20
形式電荷: 0
複雑度: 428

実験および物理化学的性質

Collision Cross Section168.2 Å² [M+Na]+ [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]

化学と産業

薬理情報

ATC Code · 2 件

C - Cardiovascular system

QC - Cardiovascular system

MeSH Pharmacological Classification · 4 件

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.

Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume.

Biologically active substances whose activities affect or play a role in the functioning of the immune system.

Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids.